CeloNova BioSciences Inc
Technology | Stents| March 02, 2017
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc.
News | Stents| February 10, 2016
CeloNova BioSciences Inc. announced this week that the first patient has been enrolled in its COBRA REDUCE trial. The...
News | Stents| September 23, 2015
CeloNova BioSciences Inc. announced that it has received conditional approval to start an investigational device...
News | November 25, 2014
CeloNova BioSciences, Inc., announced that positive first-in-man (FIM) clinical trial results found its Cobra PzF...
News | March 17, 2009
March 17, 2009 – Twelve-month data from the ATLANTA Trial shows that the CATANIA Coronary Stent System with NanoThin...
News | March 12, 2009
CATANIA Coronary Artery Stent Makes Live Case Debut During the Sociedad Venezolana de Cardiologia Intervencionista
March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during the...
News | January 25, 2009
January 26, 2009 - CeloNova BioSciences Inc.
News | December 04, 2008
December 5, 2008 - CeloNova BioSciences Inc.